Supplementary Tables S1-S3 from <i>BRAF</i> Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors

Abstract

<p>Table S1. Nucleotidic sequences of primers and probes used in the qPCR analyses. Table S2. Detailed description of BRAF copy number (CN) and mutant-allele specific quantification results. Table S3. Analysis of the association between BRAF copy number and mutant allele frequency with best response by Fisher''s exact test.</p>